Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation Study of Liposomal Paclitaxel in Chinese Patients With Advanced Solid Tumors

NCT00881101 is registered in ClinicalTrials.gov with Nanjing Sike Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT00881101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00881101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation Study of Liposomal Paclitaxel in Chinese Patients With Advanced Solid Tumors
Lead sponsor
Nanjing Sike Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2009
Completion date
December 31, 2009
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor